Mp37-12 Does Previous Transurethral Resection of the Prostate Affect the Outcomes in Robotic Assisted Radical Prostatectomy?

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy I (MP37)1 May 2024MP37-12 DOES PREVIOUS TRANSURETHRAL RESECTION OF THE PROSTATE AFFECT THE OUTCOMES IN ROBOTIC ASSISTED RADICAL PROSTATECTOMY? Abdel Rahman S. Jaber, Marcio Covas Moschovas, Shady Saikali, Ahmed Gamal, Roshane Perera, Travis Rogers, Marco Sandri, and Vipul Patel Abdel Rahman S. JaberAbdel Rahman S. Jaber , Marcio Covas MoschovasMarcio Covas Moschovas , Shady SaikaliShady Saikali , Ahmed GamalAhmed Gamal , Roshane PereraRoshane Perera , Travis RogersTravis Rogers , Marco SandriMarco Sandri , and Vipul PatelVipul Patel View All Author Informationhttps://doi.org/10.1097/01.JU.0001008948.02935.01.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Transurethral resection of the prostate (TURP) is one of the surgical options for treating enlarged prostates with lower urinary symptoms (LUTS). In this older group of patients, concomitant prostate cancer is not uncommon. However, the fibrosis and distortion of the prostate anatomy by prior TURP can potentially hinder surgical efficacy at robotic-assisted radical prostatectomy (RARP). In this scenario, the literature still lacks robust evidence of patients with previous TURP undergoing RARP. We attempted to evaluate functional and oncologic outcomes of RARP in patients with and without previous TURP. METHODS: 231 men with previous TURP underwent RARP (TURP group). These men were propensity score matched (1:3) using clinicopathological characteristics to men without previous TURP who underwent RARP (Control group). Perioperative and postoperative variables were analysed for significant differences in outcomes between groups. RESULTS: Median follow up=60 months for both groups (p=0.8). No statistically significant differences in operative measures including median EBL (100 vs. 100 mL), operative time (80 vs. 80 min), catheter time (5 vs. 5 days), hospitalization time (1 vs. 1 day), or postoperative complications. We found no significant difference between the groups in terms of potency rates (HR=0.8, 95% CI 0.49 1.36, p=0.4) and continence rates (HR=0.98, 95% CI 0.82 1.15, p=0.7). Furthermore, there were no statistically significant differences in oncological outcomes, including PSM rates (15% vs 18%, p=0.3) and biochemical recurrence (HR=1.11, 95% CI 0.76 1.62, p=0.6). CONCLUSIONS: In RARP after TURP there is often noticeable distortion of the surgical anatomy. Even in this older age group of patients, for an experienced team the procedure is safe and provides similar oncologic control and functional outcomes to RARP in patients without previous TURP. Download PPTDownload PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e607 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Abdel Rahman S. Jaber More articles by this author Marcio Covas Moschovas More articles by this author Shady Saikali More articles by this author Ahmed Gamal More articles by this author Roshane Perera More articles by this author Travis Rogers More articles by this author Marco Sandri More articles by this author Vipul Patel More articles by this author Expand All Advertisement PDF downloadLoading ...